The mechanisms of attenuation of hepatic steatosis and liver injury by probiotics are sterol regulatory element-binding protein (SREBP-1) down regulation and peroxisome proliferator-activated receptor-α (PPAR-α) up-regulation (Chávez-Tapia et al., 2015). This evidence concerns the gene SREBF1 and fatty liver disease.